Predicting who will benefit from an Expert Patients Programme self-management course

British Journal of General Practice

Volumn 58, Issue 548, 2008, Pages 198-203

  Reeves, David ^a   Kennedy, Anne ^a   Fullwood, Catherine ^a   Bower, Peter ^a   Gardner, Caroline ^a   Gately, Claire ^a   Lee, Victoria ^a   Richardson, Gerry ^b   Rogers, Anne ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Chronic disease; Outcome studies; Randomised controlled trial; Self care

Indexed keywords

AGE; ARTICLE; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SELF CONCEPT; UNITED KINGDOM;

CHRONIC DISEASE; HEALTH STATUS; HUMANS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PATIENT SELECTION; QUALITY OF LIFE; REGRESSION ANALYSIS; SELF CARE; SELF EFFICACY; SELF-HELP GROUPS;

EID: 40749157082     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp08X277320     Document Type: Article

References (26)

1. Department of Health. Our health, our care, our say: a new direction for community services. London: The Stationery Office, 2006.
2. Department of Health. The expert patient: a new approach to chronic disease management in the 21st Century. London: The Stationery Office, 2001.
3. Lorig K, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization a randomized trial. Med Care 1999; 37(1): 5-14.
4. Lorig KR, Ritter P, Stewart AL, et al. Chronic disease self-management program 2-year health status and health care utilization outcomes. Med Care 2001; 39(11): 1217-1223.
5. Kennedy A, Reeves D, Bower P, et al. The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. J Epidemiol Community Health 2007; 61(3): 254-261.
6. Fu D, Fu H, McGowan P, et al. Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: randomized controlled trial. Bull World Health Organ 2003; 81(3): 174-182.
7. Griffiths C, Motlib J, Azad A, et al. Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease. Br J Gen Pract 2005; 55(520): 831-837.
8. Lorig K, Ritter P, Gonzales VM. Hispanic chronic disease self-management - a randomized community-based outcome trial. Nurs Res 2003; 52(6): 361-369.
9. Swerissen H, Belfrage J, Weeks A, et al. A randomised control trial of a self-management program for people with a chronic illness from Vietnamese, Chinese, Italian and Greek backgrounds. Patient Educ Couns 2006; 64(1-3): 360-368.
10. Siu AMH, Chan CCH, Poon PKK, et al. Evaluation of the chronic disease self-management program in a Chinese population. Patient Educ Couns 2007; 65(1): 42-50.
11. Buszewicz M, Rait G, Griffin M, et al. Self management of arthritis in primary care: randomised controlled trial. BMJ 2006; 333(7574): 879.
12. Haas M, Groupp E, Muench J, et al. Chronic disease self-management program for low back pain in the elderly. J Manipulative Physiol Ther 2005; 28(4): 228-237.
13. Lorig K, Ritter P, Laurent D, Fries J. Long-term randomized controlled trials of tailored-print and smalt-group, arthritis self-management interventions. Med Care 2004; 42(4): 346-354.
14. Ruel MT, Rivera J, Habicht JP, Martorell R. Differential response to early nutrition supplementation: long-term effects on height at adolescence. Int J Epidemiol 1995; 24(2): 404-412.
15. Lorig K, Stewart AL, Ritter P, et al. Outcome measures for health education and other health care interventions. Thousand Oaks: Sage Publications, 1996.
16. Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spilker B (ed). Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Philadelphia: Lippincott-Raven, 1996: 191-201.
17. Pocock SJ, Assman SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 2002; 21(19): 2917-2930.
18. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edn. New York: Lawrence Erlbaum, 1998.
19. Freemantle N. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ 2001; 322(7292): 989-991.
20. Lagakos SW. The challenge of subgroup analysis - reporting without distorting. N Engl J Med 2006; 354(16): 1667-1669.
21. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001; 29(4): 1165-1188.
22. Nakegawa S. A farewell to Bonferroni: the problems of low statistical power and publication bias. Behav Ecol 2004; 15(6): 1044-1045.
23. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100(16): 9440-9445.
24. Moran MD. Arguments for rejecting the sequential Bonferroni in ecological studies. Oikos 2003; 100(2): 403-405.
25. Kennedy A, Rogers A, Gately C. Assessing the introduction of the Expert Patients Programme into the NHS: a realistic evaluation of recruitment to a national lay led self care initiative. Prim Health Care Res Dev 2005; 6(2): 137-148.
26. Kennedy A, Gately C, Rogers A. Process evaluation of the EPP - report II. Examination of the implementation of the Expert Patients Programme within the structures and locality contexts of the NHS in England. University of Manchester: National Primary Care Research and Development Centre, 2005.